Perm Visa Data for In-Vitro Diagnostic Substance Manufacturing : Top Employers, Top Jobs and Employees Trends

We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

In-Vitro Diagnostic Substance Manufacturing (NAICS code 325413) has an average growth rate of 0.11% as an Perm industry with 58 employees hired as of 2024

Top In-Vitro Diagnostic Substance Manufacturing Employers

Company	Employees	Average Wage
Indivior, Inc.	1	$45,885
Caredx	1	$235,893
Diasorin Inc.	1	$152,568
Microbiologics, Inc.	1	$74,568
Linzhi International, Inc.	1	$76,794
Zepto Life Technology, Llc	1	$88,982
Immunomycologics, Inc.; D.b.a. Immy	1	$35,235
Syntron Bioresearch, Inc.	1	$61,901
Luminex Corporation	1	$119,267

Top In-Vitro Diagnostic Substance Manufacturing Jobs

Job Title	Number of Jobs	Average Wage
Biological Technicians	1	$40,352
Financial Managers	1	$235,893
Training And Development Specialists	1	$52,478
Sales Engineers	1	$58,178

Employees Over Time vs Average Salary Over Time

The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2010 where 1 employees were hired. They peaked in 2018 with 5 employees, and have since been on a decline with the most recent number of employees being 3 in 2023.

The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2010 where the average salary was $47,237. The industry peaked in 2019 with an average salary of $118,019, and has since been on a decline with the most recent average salary being $72,134 in 2023.